Table 2.
Patients n = 6 | ||
---|---|---|
Gender | male | 2 (33 %) |
female | 4 (67 %) | |
Age | ≤ 60 | 0 (0 %) |
61-75 | 6 (100 %) | |
≥ 76 | 0 (0 %) | |
LV-function | normal | 5 (83 %) |
moderate-to-serve dysfunction | 1 (17 %) | |
Pharmacological | ACE-inhibitor | 4 (67 %) |
treatment | ß-blocker | 3 (50 %) |
Ca2+-antagonist | 1 (17 %) | |
digitoxin | 0 (0 %) | |
loop-diuretic | 3 (50 %) | |
K+-sparing diuretic | 2 (33 %) | |
thiazide-diuretic | 2 (33 %) | |
statin | 3 (50 %) | |
glyceryl trinitrate | 2 (33%) | |
Cardiosurgical procedure | coronary artery bypass | 3 (50 %) |
aortic valve replacement | 3 (50 %) | |
thoracic ancurysm repair | 1 (17 %) |